U.S. Markets closed

22nd Century announces U.S. patent issues for MPO nicotine biosynthesis gene

22nd Century announced that the US PTO has issued a patent for the N-methylputrescine oxidase gene technology. MPO is essential for production of nicotine in the tobacco plant. The US PTO granted the patent to the National Research Council Canada. 22nd Century is NRC’s exclusive worldwide licensee of MPO and other technologies.